An Exploratory Analysis of Pharmaceutical Drugs as Basic Research Tools
Drug Information Journal, ISSN: 0092-8615, Vol: 46, Issue: 2, Page: 192-196
2012
- 1Citations
- 12Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Drug development is usually seen as following a more or less linear path from publicly subsidized basic research to costly preclinical and clinical research by for-profit firms, which usually fails but occasionally succeeds in bringing highly profitable drugs to market. This study describes an additional feedback process in which pharmaceutical drugs serve as research tools. Diverse examples illustrate that the tools function of pharmaceuticals supports important advances in basic research. These often lead in turn to practical uses including new drug development. © Drug Information Association 2012.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84864798786&origin=inward; http://dx.doi.org/10.1177/0092861512436581; http://link.springer.com/10.1177/0092861512436581; http://journals.sagepub.com/doi/pdf/10.1177/0092861512436581; http://link.springer.com/content/pdf/10.1177/0092861512436581.pdf; http://journals.sagepub.com/doi/full-xml/10.1177/0092861512436581; http://link.springer.com/article/10.1177/0092861512436581/fulltext.html
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know